心肺运动测试和 2022 年肺动脉高压定义。

IF 2.2 4区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Pulmonary Circulation Pub Date : 2024-06-17 eCollection Date: 2024-04-01 DOI:10.1002/pul2.12398

Dirk Habedank, Till Ittermann, Sabine Kaczmarek, Beate Stubbe, Alexander Heine, Anne Obst, Ralf Ewert

引用次数: 0

摘要

根据 2022 年肺动脉高压的新定义（平均肺动脉压 mPAP > 20 mmHg），心肺运动测试参数可明显区分健康受试者和肺动脉高压（PH）患者。显示 PH 的临界值是峰值 VO2 ≤ 16.7 mL/min/kg （Youden-Index YI = 0.79）、petCO2@AT ≤ 34 mmHg （YI = 0.67）和 VE/VCO2@AT ≤ 30 （YI = 0.76）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Cardiopulmonary exercise testing and the 2022 definition of pulmonary hypertension.

Parameters of cardiopulmonary exercise testing significantly discriminate between healthy subjects and patients with pulmonary hypertension (PH), also according to the new 2022 definition of pulmonary hypertension (mean pulmonary arterial pressure mPAP > 20 mmHg). The cut-offs indicating on PH were peakVO₂ ≤ 16.7 mL/min/kg (Youden-Index YI = 0.79), p_etCO₂@AT ≤ 34 mmHg (YI = 0.67), and VE/VCO₂@AT ≤ 30 (YI = 0.76).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Pulmonary Circulation Medicine-Pulmonary and Respiratory Medicine

CiteScore

4.20

自引率

11.50%

发文量

153

审稿时长

15 weeks

期刊介绍： Pulmonary Circulation''s main goal is to encourage basic, translational, and clinical research by investigators, physician-scientists, and clinicans, in the hope of increasing survival rates for pulmonary hypertension and other pulmonary vascular diseases worldwide, and developing new therapeutic approaches for the diseases. Freely available online, Pulmonary Circulation allows diverse knowledge of research, techniques, and case studies to reach a wide readership of specialists in order to improve patient care and treatment outcomes.